Corrected Proof scheduled for 11 (2)

Opioid Use among Women on a Stable Methadone Dose

Authors Information
Article Notes and Dates
To Cite : Alammehrjerdi Z, Massah O, Farhoudian A, Shishehgar S, Moradi A, et al. Opioid Use among Women on a Stable Methadone Dose, Iran J Psychiatry Behav Sci. Online ahead of Print ;In Press(In Press):e9867. doi: 10.5812/ijpbs.9867.
Abstract
1. Background
2. Objectives
3. Materials and Methods
4. Study Procedure
5. Results
6. Discussion
7. Conclusion
Acknowledgements
Footnotes
References
  • 1. Alam-mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran. Asian J Psychiatr. 2015; 15: 78-83[PubMed]
  • 2. Springer SA, Larney S, Alam-mehrjerdi Z, Altice FL, Metzger D, Shoptaw S. Drug treatment as HIV prevention among women and girls who inject drugs from a global perspective: progress, gaps and future direction J Acquir Immune Defic Syndr. 2015; 69(1)-61[PubMed]
  • 3. Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016; 111(10): 1836-47[DOI][PubMed]
  • 4. Moharreri MR. General view of drug abuse in Iran and one-year report of outpatient treatment of opiate addiction in the city of Shiraz. NIDA Res Monogr. 1978; (19): 69-81[PubMed]
  • 5. Nassirimanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic republic of Iran. The Beckley foundation drug policy programme. 2005;
  • 6. UNAIDS . Global AIDS response progress reporting of Iran 2015;
  • 7. Fahimfar N, Sedaghat A, Hatami H, Kamali K, Gooya M. Counseling and harm reduction centers for vulnerable women to HIV/AIDS in Iran. Iran J Public Health. 2013; 42: 98-104[PubMed]
  • 8. Jafari S, Movaghar A, Baharlou S, Spittal P, Craib K. Trends of substance use in southern Iran: a qualitative study. Int J Epidemiol. 2007; 6(1): 1-7
  • 9. Rahimi-Movaghar A, Malayerikhah Langroodi Z, Delbarpour Ahmadi S, Amin Esmaeili M. a qualitative study of specific needs of women for treatment of addiction. IJPCP. 2011; 17(2): 116-25
  • 10. Roshanfekr P, Noori R, Dejman M, Fathi Geshnigani Z, Rafiey H. Drug use and sex work among at-risk women: a qualitative study of initial factors. Iran J Psychiatry Behav Sci. 2015; 9(2): 953[DOI][PubMed]
  • 11. Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, et al. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction. 2016; 111(4): 695-705[DOI][PubMed]
  • 12. Yen CF, Lin HC, Wang PW, Ko CH, Lee KH, Hsu CY, et al. Heroin craving and its correlations with clinical outcome indicators in people with heroin dependence receiving methadone maintenance treatment. Compr Psychiatry. 2016; 65: 50-6[DOI][PubMed]
  • 13. Zhang L, Zou X, Zhang D, Li X, Zhao P, Ling L. Investigation of repeat client drop-out and re-enrolment cycles in fourteen methadone maintenance treatment clinics in Guangdong, China. PLoS One. 2015; 10(10): 139942[DOI][PubMed]
  • 14. Banys P, Tusel DJ, Sees KL, Reilly PM, Delucchi KL. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program. J Subst Abuse Treat. 1994; 11(3): 225-32[PubMed]
  • 15. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med. 1993; 119(1): 23-7[PubMed]
  • 16. Strauss A, Corbin J. Basics of qualitative research: grounded theory procedures and techniques. 1991;
  • 17. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995; 311(6996): 42-5[PubMed]
  • 18. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence. Subst Abuse Rehabil. 2012; 3: 37-43[DOI][PubMed]
  • 19. Bryant J, Treloar C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev. 2007; 26(3): 287-93[DOI][PubMed]
  • 20. Navidian A, Kermansaravi F, Tabas EE, Saeedinezhad F. Efficacy of group motivational interviewing in the degree of drug craving in the addicts under the methadone maintenance treatment (MMT) in south east of Iran. Arch Psychiatr Nurs. 2016; 30(2): 144-9[DOI][PubMed]
  • 21. Alammehrjerdi Z, Ezard N, Clare P, Babhadiashar B, Shakeri A, Mokri A. Brief cognitive-behavioural therapy for methamphetamine use among methadone-maintained women: a multicentre randomised controlled tria J Addict Res Ther 2016; 7(4): 1-8[DOI]
  • 22. Higgs P, Owada K, Hellard M, Power R, Maher L. Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity. Cult Health Sex. 2008; 10(7): 681-96[DOI][PubMed]
  • 23. Olsson TM, Fridell M. Women with comorbid substance dependence and psychiatric disorders in Sweden: a longitudinal study of hospital care utilization and costs. BMC Health Serv Res. 2015; 15: 224[DOI][PubMed]
  • 24. Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010; 33(2): 339-55[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Iranian Journal of Psychiatry and Behavioral Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check